Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Total Liabilities
Everything the company owes to creditors and other parties.
Quanterix CorporationNASDAQ: QTRX
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 5.5% from a year ago
Total liabilities stood at $84.53M at the end of Q1 FY2026, up 5.5% from a year earlier and down 31.3% from the prior quarter. Over 3 fiscal years it compounded at +17.6% a year.
Context
- Total liabilities amounted to 23.1% of total assets at the end of Q1 FY2026, up 2.8 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +5.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 123.04M USD
- Year-over-year change
- +60.8%
- 4-year CAGR
- +17.0%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 123.04M | +60.8% |
| FY2024 | 2024-12-31 | 76.5M | -2.7% |
| FY2023 | 2023-12-31 | 78.61M | +3.9% |
| FY2022 | 2022-12-31 | 75.65M | +15.4% |
| FY2021 | 2021-12-31 | 65.56M | — |
Total Liabilities vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's Mar 2026 total liabilities of $84.53M is the 4th highest of the 11 companies compared; the peer median is $62.16M.
- Its year-over-year change of +5.5% is the 8th highest of 11, against a peer median of +12.3%.
- Total liabilities amounts to 23.1% of total assets for QTRX, versus a peer median of 43.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $8.29B | +93713.8% | +2.6% | 3.9% | |
| Mar 2026 | $137.77M | +4.9% | -3.7% | 55.2% | |
| Mar 2026 | $103.02M | -6.7% | -0.4% | 36.0% | |
| Mar 2026 | $84.53M | +5.5% | +17.6% | 23.1% | |
| Mar 2026 | $70.62M | +17.3% | +60.8% | 70.8% | |
| Mar 2026 | $68.52M | +31.7% | -28.7% | 66.6% | |
| Mar 2026 | $55.8M | +7.2% | -1.0% | 50.9% | |
| Mar 2026 | $52.52M | +43.5% | -3.7% | 28.1% | |
| Mar 2026 | $51.57M | +24.8% | +53.0% | 26.1% | |
| Mar 2026 | $35.26M | -26.8% | -16.3% | 95.0% | |
| Dec 2025 | $22.43M | +7.4% | -15.6% | 13.8% | |
| Peer median (excluding QTRX) | $62.16M | +12.3% | -2.4% | 43.4% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 396.47M | 338.74M | 174.42M | 56.71M | 29.84M |
| Short-term Investments | 0 | 0 | 146.9M | 232.41M | 88.39M |
| Net Receivables | 23.79M | 19.02M | 25.41M | 32.14M | 29.97M |
| Inventory | 22.19M | 16.96M | 26.12M | 32.78M | 54.76M |
| Other Current Assets | 6.51M | 6.8M | 9.23M | 9.56M | 9.29M |
| Total Current Assets | 448.96M | 381.52M | 382.1M | 363.59M | 212.26M |
| Property, Plant & Equipment (Net) | 29.45M | 41.03M | 36.18M | 33.49M | 40.34M |
| Goodwill | 9.63M | 0 | 0 | 0 | 26.38M |
| Intangible Assets | 10.53M | 7.52M | 6.03M | 4.03M | 131.79M |
| Long-term Investments | 2.58M | 2.6M | 0 | 0 | 0 |
| Tax Assets | 4.99M | 7.77M | 0 | 0 | 0 |
| Other Non-current Assets | 378K | (6.86M) | 4.26M | 5.42M | 8.01M |
| Total Non-current Assets | 57.56M | 52.06M | 46.47M | 42.94M | 206.51M |
| Total Assets | 506.51M | 433.58M | 428.57M | 406.53M | 418.77M |
| Account Payables | 9.21M | 3.84M | 5.05M | 6.95M | 13.57M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 822K | 1.02M | 0 |
| Deferred Revenue | 6.36M | 8.64M | 9.47M | 8.83M | 20.73M |
| Other Current Liabilities | 13.49M | 11.04M | 14.17M | 12.62M | 21.85M |
| Total Current Liabilities | 36.98M | 31.35M | 38.98M | 42.01M | 74.76M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 7.02M | 9.24M | 1.18M | 800K | 8.1M |
| Deferred Revenue (Non-current) | 1.1M | 1.42M | 1.23M | 1.07M | 5.83M |
| Other Non-current Liabilities | 0 | (7.77M) | 0 | 0 | 5.02M |
| Total Non-current Liabilities | 28.59M | 44.3M | 39.63M | 34.49M | 48.27M |
| Total Liabilities | 65.56M | 75.65M | 78.61M | 76.5M | 123.04M |
| Common Stock | 37K | 37K | 38K | 39K | 47K |
| Retained Earnings | (305.46M) | (403.2M) | (431.55M) | (470.08M) | (577.23M) |
| Accumulated OCI | 441K | (2.54M) | (1.67M) | (3.08M) | (723K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 440.95M | 357.93M | 349.96M | 330.04M | 295.73M |
| Total Debt | 21.89M | 44.1M | 41.46M | 37.37M | 37.24M |
| Net Debt | (374.57M) | (294.64M) | (132.96M) | (19.34M) | 7.4M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.